Outcomes According to ALK Status Determined by Central IHC or FISH in Patients with ALK-Positive NSCLC Enrolled in the Phase III ALEX Study

We retrospectively examined progression-free survival (PFS) and response by ALK fluorescence in-situ hybridization (FISH) status in patients with advanced ALK immunohistochemistry (IHC)-positive non-small-cell lung cancer (NSCLC) in the ALEX study. 303 treatment-naïve patients were randomized to rec...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of thoracic oncology 2020-10
Hauptverfasser:	Mok, Tony, Peters, Solange, Camidge, D Ross, Noé, Johannes, Gadgeel, Shirish, Ignatius Ou, Sai-Hong, Kim, Dong-Wan, Konopa, Krzysztof, Pozzi, Emanuela, Liu, Ting, Loftin, Isabell R, Williams, Crystal, Shaw, Alice T
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!